Stockreport

Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Lantern Pharma Inc.  (LTRN) 
PDF Year of Clinical Validation and Strategic Expansion Across Pipeline, AI Platform Advances Towards Commercialization, and Global Trial MilestonesLP-300 Phase 2 HARMONICâ„¢ [Read more]